Outline (Jul.8, 2013 - Mar. 31, 2016)
Mission: to “realize the application of human iPSC-derived cardiomyocytes, hepatocytes and neurons for drug safety evaluations by both technological advancement and including policy recommendations.”
Organizational structure
An Executive Committee
- Consortium Leader
Norimasa Miyamoto, Ph.D. (Eisai Co., Ltd.) - Cardiomyocyte Team Leader
Kiyosi Takasuna, Ph.D. (Daiichisankyo Co., Ltd.) - Hepatocyte Team Leader
Tomoaki Inoue, Ph.D. (Chugai Pharmaceutical Co., Ltd.) - Neuron Team Leader
Yasuhiro Itano, Ph.D. (Teijin Pharma Ltd.) - Cell Characterization Team Leader
Tadahiro Shinozawa, Ph.D. (Takeda Pharmaceutical Co., Ltd.) - Information Sharing Promotion Leader (Website management & Inquires)
Tesuro Araki, Ph., D. (Asahi Kasei Pharma Corp.)
« Back
